You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
14 August 2026 - Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a San Francisco-based commercial stage biotechnology company, announced on Thursday that VEPPANUTM (vepdegestrant) is now available by prescription in the United States for the treatment of...
14 August 2026 - Innorna, a Hong Kong-based clinical-stage biotech company advancing RNA medicines, announced on Thursday that it has been nominated for the 2026 Prix Galien USA Best Startup Award.Innorna was shortlisted in the Best Startup category,...
14 August 2026 - Elephas Biosciences Corporation, a US-based private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced on Thursday an exclusive partnership with India-based Neuberg Diagnost...
14 August 2026 - BioCytics, Inc., a North Carolina-based biotechnology company, and LIDE Biotech, a China-based biotechnology company, announced on Thursday the formation of a strategic alliance to develop advanced screening platforms and companion d...
13 August 2026 - US biopharmaceutical company PTC Therapeutics Inc (NASDAQ:PTCT) announced on Wednesday that it was selected as the winning bidder to acquire ST-920, a BLA-stage, one-time administered AAV gene therapy for Fabry disease, from Sangamo ...
12 August 2026 - Swedish pharmaceutical company EQL Pharma AB (STO: EQL) announced on Wednesday that it has licensed its methenamine hippurate product Memprex for sale in Hungary through local pharmaceutical company Pharmacenter, which develops and c...